The grades of five medical devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Winner Medical Group (WWIN) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
ERBA Diagnostics, Inc. (ERB) gets a higher grade this week, advancing from a B last week to an A. For more information, get Portfolio Grader’s complete analysis of ERB stock.
The Spectranetics Corporation (SPNC) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system, many of which are used with its proprietary excimer laser system. For more information, get Portfolio Grader’s complete analysis of SPNC stock.
TearLab’s (TEAR) ratings are looking better this week, moving up to a B from last week’s C. TearLab is an in-vitro diagnostics company. For more information, get Portfolio Grader’s complete analysis of TEAR stock.
Accuray Incorporated (ARAY) earns a B this week, jumping up from last week’s grade of C. Accuray designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. Shares of the stock have been changing hands at an unusually rapid pace, twice the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of ARAY stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
